Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT00821197
Other study ID # AT-0910-ST
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date February 2011
Est. completion date May 2025

Study information

Verified date September 2021
Source Oslo University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main study objective: To evaluate long-limb gastric bypass (150 cm alimentary limb) vs. "distal" gastric bypass (common channel 150 cm) in the treatment of superobesity (BMI 50-60 kg/m2). The main study hypothesis: Distal bypass accomplish an estimated 10-20 % larger weightloss than long-limb gastric bypass 1 year after surgery. Patients subject to distal bypass have more gastrointestinal side effects and more extensive nutritional deficiences compared to long-limb gastric bypass.


Description:

Technical data will later be published in detail


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 115
Est. completion date May 2025
Est. primary completion date May 2015
Accepts healthy volunteers No
Gender All
Age group 20 Years to 60 Years
Eligibility Inclusion Criteria: - BMI 50 - 60 kg/m2 at admission for evaluation for bariatric surgery - BMI 48 - 62 kg/m2 at study inclusion - informed consent - scheduled for bariatric surgery Exclusion Criteria: - previous bariatric surgery - previous major abdominal surgery - previous history or established urolithiasis - viral hepatitis, liver cirrhosis of any kind - factors making the patient not eligible to understand and commit to the study protocol (severe psychiatric disease or drug/narcotic abuse)

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
long-limb gastric bypass
Laparoscopic long-limb gastric bypass (150 cm alimentary limb, 50 cm biliopancreatic limb)
distal gastric bypass
Laparoscopic distal gastric bypass (150 cm common channel, 50 cm biliopancreatic limb)

Locations

Country Name City State
Norway Aker university Hospital, Surgical Dep., The Hospital of Vestfold, Surgical Dep. Oslo

Sponsors (2)

Lead Sponsor Collaborator
Oslo University Hospital The Hospital of Vestfold

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary Primary outcome: weight loss physical examination 2 years postoperatively
Secondary Secondary outcome: Quality of life questionnaire 2 years postoperative
Secondary Adverse events medical history, journals 2 years postoperative
Secondary Number of patients with vitamin deficiencies Blood samples 2 years postoperative
Secondary Number of patients with mineral deficiencies Blood samples 2 years postoperative
Secondary Number of participants with malnutrition Blood samples 2 years postoperative
Secondary Weight loss 5 year physical examination 5 year postoperative
Secondary Health related Quality of life questionnaire 5 years postoperative
Secondary Number of patients with malnutrition Blood samples 5 years postoperative
Secondary Number of patients with mineral deficiencies Blood samples 5 years postoperative
Secondary Number of patients with vitamin deficiencies Blood samples 5 years postoperative
Secondary Adverse events Medical history, journals 5 years
Secondary Weight loss 10 years Weight measure 10 years postoperative
Secondary Adverse events Medical history, journals 10 years postoperative
Secondary Number of patients with malnutrition Blood samples 10 years postoperative
Secondary Number of patients with mineral deficiencies Blood samples 10 years postoperative
Secondary Number of patients with vitamin deficiencies Blood samples 10 years postoperative
Secondary Health related Quality of life questionnaire 10 years postoperative
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2

External Links